TheraOp gGmbH

TheraOp gGmbH is engaged in clinical research for locally advanced non-small-cell lung cancer, with a focus on unresectable stage III disease and tumors showing PD-L1 expression.

• Non-small-cell lung cancer
• Locally advanced unresectable disease
• Stage III lung cancer
• PD-L1-positive tumors

The sponsor’s research activity centers on treatment strategies for advanced lung malignancy in a setting where local control and systemic disease management are both clinically relevant.